Cite
HARVARD Citation
Ding, J. et al. (2022). Telitacicept following plasma exchange in the treatment of subjects with recurrent neuromyelitis optica spectrum disorders: A single‐center, single‐arm, open‐label study. CNS neuroscience & therapeutics. pp. 1613-1623. [Online].